Bruce C. Cozadd
2013
In 2013, Bruce C. Cozadd earned a total compensation of $8.3M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $1,056,500 |
---|---|
Option Awards | $3,478,750 |
Salary | $771,154 |
Stock Awards | $2,956,500 |
Other | $3,622 |
Total | $8,266,526 |
Cozadd received $3.5M in option awards, accounting for 42% of the total pay in 2013.
Cozadd also received $1.1M in non-equity incentive plan, $771.2K in salary, $3M in stock awards and $3.6K in other compensation.
Rankings
In 2013, Bruce C. Cozadd's compensation ranked 586th out of 12,286 executives tracked by ExecPay. In other words, Cozadd earned more than 95.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 586 | 95th |
Manufacturing | 181 | 96th |
Chemicals And Allied Products | 44 | 97th |
Drugs | 26 | 98th |
Pharmaceutical Preparations | 24 | 97th |
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2013.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019